Istituto per lo Studio e la Prevenzione Oncologica

Recent papers from Istituto per lo Studio e la Prevenzione Oncologica

1. Sustainability measurement tools in public health and their applicability to cancer screening programs: a scoping review within the EUCanScreen joint actionBMC Public Health · 2026
2. Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-upThe Lancet · 2014
3. Three-year risk of colorectal cancer by faecal haemoglobin concentration in subjects with a negative FIT.2026
4. Scaling temporal resolution from mice to humans: Challenges and innovations in preclinical imaging of translational modelsThe Journal of Physiology · 2026
5. Advancing complement inhibition for the treatment of malarial anemia: a translational roadmapMalaria Journal · 2026
6. Radiological review of interval breast cancers following screening with DBT + DM or DM: results from MAITA project randomized trialsLa radiologia medica · 2026
7. Back to the Future of qEEG: Lifespan Normative Modeling of Spectral Ratios and Functional Indices with Potential Applications to Therapeutic MonitoringBrain Topography · 2026
8. Anemia and Patient‐Reported Outcomes in Patients With Paroxysmal Nocturnal Hemoglobinuria: A Real‐World Observational StudyeJHaem · 2026
9. Infection prevention and control procedures in nursing homes in the piedmont region of Italy: results from two regional surveys (2021–2024)Antimicrobial Resistance and Infection Control · 2026
10. Micro Aberration Scatter Index (MASI) as an objective proxy for contrast sensitivity after keratorefractive surgery: a prospective observational studyBMC Ophthalmology · 2026
11. Prophylaxis and management of thromboembolism in pnh patients: an italian surveyAnnals of Hematology · 2026
12. Human-Mouse Convergence in Metabolic Dysfunction-Associated Steatotic Liver Disease: Mouse Model Selection and Non-Invasive Diagnostic StrategiesLivers · 2026
13. Iptacopan monotherapy resulted in increased hemoglobin level in patients with PNH and hemoglobin ≥10 g/dL after anti‐C5 therapyHemaSphere · 2026
14. Real-world outcomes of biomarker-guided multidisciplinary management in localized and metastatic gastric cancer.Journal of Clinical Oncology · 2026
15. Consistent Metabolomic and Genetic Evidence Supports Acisoga as a Key Contributor to Colorectal Neoplasia ProgressionCancer Epidemiology Biomarkers & Prevention · 2026
16. Risk-stratified cancer screening: a consensus-based conceptual framework from EUCanScreenEuropean Journal of Cancer · 2026
17. The co-creation of a document to guide the use of self-sampling for human papillomavirus screening in ItalyJournal of Medical Screening · 2026
18. Recommendations for the treatment of endometrial cancer in settings with limited resources: report from the International Gynecological Cancer Society consensus meetingSHILAP Revista de lepidopterología · 2026
19. Abstract PS3-01-12: Wisdom and mypebs: personalized breast cancer screening trials operating in distinct international contextsClinical Cancer Research · 2026
20. MAPK15 controls intracellular lipid uptake and protects mammalian liver from steatotic diseaseHepatology Communications · 2026